Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if RAD001 treatment will shrink or slow the growth
of the vestibular schwannoma(s) in Neurofibromatosis 2 (NF2) patients.